文献速递炎症性肠病

IL-20通过调控上皮细胞IFN/STAT2信号控制实验性结肠炎的缓解

IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling.
PubMed 文献 · Gut · 2024-01-05

该研究在小鼠实验性结肠炎模型及炎症性肠病(IBD)患者样本中探究白细胞介素(IL)-20的作用。发现IL-20由肠上皮细胞产生,可抑制干扰素(IFN)-STAT2信号及其诱导的坏死性凋亡,IL-20缺失小鼠对右旋糖酐硫酸钠(DSS)诱导的结肠炎更易感,而给予IL-20可抑制野生型动物的结肠炎活动。

要点

  • IBD缓解期IL20水平诱导升高,抗肿瘤坏死因子应答者显著高于无应答者。
  • Il20-/-、Il20ra-/-和Il20rb-/-小鼠较野生型对照对DSS诱导结肠炎更易感。
  • IL-20可显著阻断肠上皮细胞来源类器官中IFN/STAT2诱导的坏死性凋亡。

核心结论

  • IL-20通过干扰肠上皮细胞中的IFN/STAT2死亡信号通路来控制结肠炎和黏膜愈合。
  • 这些结果提示通过调控IL-20控制的STAT2信号抑制肠道炎症的新方向。

研究设计与样本

  • 研究在缺乏IL-20及信号转导和转录激活因子(STAT)2信号通路组分的小鼠中诱导实验性结肠炎。
  • 采用活体成像、高分辨率微型内镜和组织学评估肠道炎症。
  • 采用RNA测序(RNA-Seq)、RNAscope和基因本体分析、蛋白质印迹和共免疫沉淀、共聚焦显微镜及肠上皮细胞(IEC)来源的三维类器官探究分子机制。
  • 结果通过RNA-Seq、类器官和免疫染色在IBD患者及非IBD对照样本中验证。

主要发现

  • IBD中IL20水平在缓解期被诱导,且抗肿瘤坏死因子应答者显著高于无应答者。
  • IBD患者IEC上存在IL-20RA和IL-20RB,IL-20在这些细胞中诱导STAT3并抑制干扰素(IFN)-STAT2信号。
  • 在IBD、实验性DSS诱导结肠炎和黏膜愈合中,IEC是IL-20的主要产生者。
  • 与野生型对照相比,Il20-/-、Il20ra-/-和Il20rb-/-小鼠对实验性DSS诱导结肠炎更易感。
  • IL-20缺失与小鼠中IFN/STAT2活性增加相关,IL-20可显著阻断IEC来源类器官中IFN/STAT2诱导的坏死性凋亡。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to investigate the role of interleukin (IL)-20 in IBD and experimental colitis. DESIGN: Experimental colitis was induced in mice deficient in components of the IL-20 and signal transducer and activator of transcription (STAT)2 signalling pathways. In vivo imaging, high-resolution mini-endoscopy and histology were used to assess intestinal inflammation. We further used RNA-sequencing (RNA-Seq), RNAScope and Gene Ontology analysis, western blot analysis and co-immunoprecipitation, confocal microscopy and intestinal epithelial cell (IEC)-derived three-dimensional organoids to investigate the underlying molecular mechanisms. Results were validated using samples from patients with IBD and non-IBD control subjects by a combination of RNA-Seq, organoids and immunostainings. RESULTS: In IBD, IL20 levels were induced during remission and were significantly higher in antitumour necrosis factor responders versus non-responders. IL-20RA and IL-20RB were present on IECs from patients with IBD and IL-20-induced STAT3 and suppressed interferon (IFN)-STAT2 signalling in these cells. In IBD, experimental dextran sulfate sodium (DSS)-induced colitis and mucosal healing, IECs were the main producers of IL-20. Compared with wildtype controls, Il20-/-, Il20ra-/- and Il20rb-/- mice were more susceptible to experimental DSS-induced colitis. IL-20 deficiency was associated with increased IFN/STAT2 activity in mice and IFN/STAT2-induced necroptotic cell death in IEC-derived organoids could be markedly blocked by IL-20. Moreover, newly generated Stat2ΔIEC mice, lacking STAT2 in IECs, were less susceptible to experimental colitis compared with wildtype controls and the administration of IL-20 suppressed colitis activity in wildtype animals. CONCLUSION: IL-20 controls colitis and mucosal healing by interfering with the IFN/STAT2 death signalling pathway in IECs. These results indicate new directions for suppressing gut inflammation by modulating IL-20-controlled STAT2 signals.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Chiriac MT, Hracsko Z, Günther C, et al. IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling. Gut. 2024. PMID: 37884352. doi:10.1136/gutjnl-2023-329628

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。